NMPA Approval

Methylphenidate Hydrochloride Extended-release Chewable Tablets

Approval Number

国药准字HJ20230144

Company

nextwave pharmaceuticals inc,a subsidiary of tris pharma inc

Registration Date

December 13, 2023

Drug Information

Generic Name

盐酸哌甲酯缓释咀嚼片

Dosage Form

片剂

Strength

30mg

Drug Type

化学药品

Registration Date

December 13, 2023

Expiry Date

December 12, 2028

Company Name

nextwave pharmaceuticals inc,a subsidiary of tris pharma inc

Company Address

2033 Us Highway 130, Monmouth Junction, NJ 08852 United States of America

Company Address

2033 US 130, Monmouth Junction, NJ 08852 United States of America

Empowering clinical research with data-driven insights and AI-powered tools.

盐酸哌甲酯缓释咀嚼片 - NMPA 批准文号 | MedPath